BRISTOL MYERS SQUIBB CO (BMY) SEC Filings & Financial Intelligence
BRISTOL MYERS SQUIBB CO (BMY) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BMY
CIK: 14272
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJeffrey Ellis
Audit LocationMorristown, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-11-06 | 2026-11-05 | FORM 4 | 0001656082-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-11-06 | — | 144 Filing | 0001628280-26-071514 | View SEC Doc Filr Page |
| 4 | 2026-11-04 | 2026-11-03 | FORM 4 | 0001975719-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-11-03 | 2026-11-01 | FORM 4 | 0001543747-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-11-03 | 2026-11-01 | FORM 4 | 0001917325-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-11-03 | 2026-11-01 | FORM 4 | 0001908769-26-000006 | View SEC Doc Filr Page |
| 10-Q | 2026-10-29 | 2026-09-30 | 10-Q | 0000014272-26-000024 | View SEC Doc Filr Page |
| 8-K | 2026-10-29 | 2026-10-29 | 8-K | 0000014272-26-000022 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-02 | FORM 4 | 0001995058-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001269070-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001688276-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001359067-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001418949-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001323134-26-000024 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-09 | FORM 4 | 0002080176-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-09-09 | — | 144 Filing | 0001959173-26-006809 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0002070839-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-25 | FORM 4 | 0002012588-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-08-25 | — | 144 Filing | 0001959173-26-006424 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000422 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-01 | FORM 4 | 0002080176-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-01 | FORM 4 | 0001995058-26-000005 | View SEC Doc Filr Page |
| 10-Q | 2026-07-30 | 2026-06-30 | 10-Q | 0000014272-26-000020 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0000014272-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | FORM 4 | 0001269070-26-000009 | View SEC Doc Filr Page |